ARCHIVES

IOM Review Of Duke Genomics Trials To Focus On Validation, Scientific Criteria

This article is from The Cancer Letter archive.

Vol. 36 No. 38 | October 22, 2010

Download PDF Visit The Full Archive

Related Articles

Revlimid Plus Steroid Effective In Clinical Trial

November 30, 2007

No Justification Provided: AAUP Demands Reinstatement of Faculty Denied Tenure Renewal at MD Anderson

May 16, 2014

Pharmacogenomics May Lead To Individualized Treatment

June 25, 2004

In Brief: Reviewed CCOP Applications Won’t Be Funded; Potter Recruiting For New Medical Oncology Chief

September 30, 1983

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

May 30, 2014

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

January 8, 1993